Rapid, point-of-care, low-cost aneuploidy screening using a handheld nanopore-based DNA sequencer
Unmet Medical Need: Testing for aneuploidy (the presence of an abnormal number of chromosomes) is an integral part of fertility and prenatal care. Current technologies for testing are expensive, slow, and requires that specimens be sent to centralized high-complexity lab. There is a need for an efficient, point-of-care screening tool for aneuploidy.
Envisioned Healthcare Product: A rapid, low cost, point-of-care aneuploidy testing using disposable, hand-held nanopore-based DNA sequencing.
Funding Cycle: 2019-2020